Drug Makers Encounter Cultural Differences in Asia

Article

BANGKOK, Thailand-Makers of pharmaceuticals for the mentally ill were excited at the possibility of selling their products to more than 2 billion people in Asia.

What they didn't expect was the prevalence of shamans and fortune tellers treating such patients.

When Eli Lilly and Co. decided to research the Asian market in 1980, many doctors told them there was no mental illness in the region. Healthcare workers and the public had no knowledge of depression or schizophrenia, even though US researchers estimate Asians suffer from depression as frequently as Americans.

An estimated 3% of both populations are afflicted.

Doctors frequently reported patients coming to their hospitals for somatic complaints like pain, lack of sexual response, hyperventilation or paralysis of limbs. Physicians blamed these symptoms on their patient's lack of expressing their feelings.

However, American pharmaceutical companies, examining the possibly of treating the continent, have now invested millions of dollars into education programs for Asian healthcare workers and funded national public health campaigns.

Eli Lilly sponsors postgraduate research and courses for Asian doctors studying psychiatry. Johnson & Johnson brought US schizophrenia advocacy groups and Asian families with schizophrenic relatives together. Johnson & Johnson hosts seminars for psychiatrists to teach them about treating the mentally ill.

Even though many of these doctors agree that Western medication could help the Asian population, they understand that educating the public about a problem they don't believe to exist, will not be easy.

Information from The Wall Street Journal.

Recent Videos
Pathogen Playbook Presenter: Sharon Ward-Fore, BS, MS, MT(ASCP), CIC, FAPIC
Mark Wiencek, PhD
Rebecca Crapanzano-Sigafoos, DrPH, CIC, AL-CIP, FAPIC
The CDC’s updated hospital respiratory reporting requirement has added new layers of responsibility for infection preventionists. Karen Jones, MPH, RN, CIC, FAPIC, clinical program manager at Wolters Kluwer, breaks down what it means and how IPs can adapt.
Studying for the CIC using a digital tablet and computer (Adobe Stock 335828989 by NIKCOA)
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Infection Control Today's Conversations with the HSPA President, Arlene Bush, CRCST, CER, CIS, SME, DSMD, CRMST
Cheron Rojo, BS, FCS, CHL,  CER, CFER, CRCST
Matthias Tschoerner, Dr Sc
Standardizing Cleaning and Disinfection
Related Content